Australian biotech company Recce Pharmaceuticals has welcomed a new US plan for medical countermeasures against dangerous infections.
Why it mattersDrug-resistant infections can make ordinary treatments fail, so public funding may speed the search for new antibiotics.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.